Advertisement
Singapore markets closed
  • Straits Times Index

    3,287.75
    -5.38 (-0.16%)
     
  • S&P 500

    5,071.63
    +1.08 (+0.02%)
     
  • Dow

    38,460.92
    -42.77 (-0.11%)
     
  • Nasdaq

    15,712.75
    +16.11 (+0.10%)
     
  • Bitcoin USD

    64,042.04
    -2,574.62 (-3.86%)
     
  • CMC Crypto 200

    1,358.29
    -24.28 (-1.76%)
     
  • FTSE 100

    8,097.91
    +57.53 (+0.72%)
     
  • Gold

    2,341.80
    +3.40 (+0.15%)
     
  • Crude Oil

    83.10
    +0.29 (+0.35%)
     
  • 10-Yr Bond

    4.6520
    +0.0540 (+1.17%)
     
  • Nikkei

    37,628.48
    -831.60 (-2.16%)
     
  • Hang Seng

    17,284.54
    +83.27 (+0.48%)
     
  • FTSE Bursa Malaysia

    1,569.25
    -2.23 (-0.14%)
     
  • Jakarta Composite Index

    7,155.29
    -19.24 (-0.27%)
     
  • PSE Index

    6,574.88
    +2.13 (+0.03%)
     

Alcon (ALC) Reports Q4 Earnings: What Key Metrics Have to Say

For the quarter ended December 2023, Alcon (ALC) reported revenue of $2.33 billion, up 8.2% over the same period last year. EPS came in at $0.70, compared to $0.42 in the year-ago quarter.

The reported revenue compares to the Zacks Consensus Estimate of $2.34 billion, representing a surprise of -0.22%. The company delivered an EPS surprise of +2.94%, with the consensus EPS estimate being $0.68.

While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.

Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.

ADVERTISEMENT

Here is how Alcon performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

  • Net sales by region- United States: $1.07 billion versus the two-analyst average estimate of $1.02 billion.

  • Net sales by region- International: $1.27 billion versus the two-analyst average estimate of $1.31 billion.

  • Net Sales- Total Surgical- Equipment/other: $226 million versus the five-analyst average estimate of $214.66 million. The reported number represents a year-over-year change of +10.8%.

  • Net Sales- Total Vision care: $980 million compared to the $982.85 million average estimate based on five analysts. The reported number represents a change of +11.2% year over year.

  • Net Sales- Total Surgical- Consumables: $688 million versus $680.04 million estimated by five analysts on average. Compared to the year-ago quarter, this number represents a +8.2% change.

  • Revenues- Other revenues: $20 million versus the five-analyst average estimate of $23.26 million.

  • Net Sales- Total Vision Care- Contact lenses: $579 million versus the five-analyst average estimate of $585.55 million. The reported number represents a year-over-year change of +9.3%.

  • Net Sales- Total Vision Care- Ocular health: $401 million compared to the $397.30 million average estimate based on five analysts. The reported number represents a change of +14.3% year over year.

  • Net Sales- Total Surgical- Implantables: $438 million versus $459.04 million estimated by five analysts on average. Compared to the year-ago quarter, this number represents a +0.9% change.

  • Net Sales- Total Surgical: $1.35 billion versus the four-analyst average estimate of $1.35 billion. The reported number represents a year-over-year change of +6.1%.

View all Key Company Metrics for Alcon here>>>

Shares of Alcon have returned +5.9% over the past month versus the Zacks S&P 500 composite's +3.8% change. The stock currently has a Zacks Rank #4 (Sell), indicating that it could underperform the broader market in the near term.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Alcon (ALC) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research